Use of tobacco products and gastrointestinal morbidity: an endoscopic population-based study (the Kalixanda study)

@article{Aro2010UseOT,
  title={Use of tobacco products and gastrointestinal morbidity: an endoscopic population-based study (the Kalixanda study)},
  author={Pertti Aro and Jukka Ronkainen and Tom Storskrubb and Michael Vieth and Lars Engstrand and Sven-erik Johansson and Elisabeth Bolling-Sternevald and Gunilla Bolinder and Kjell Alving and Nicholas J Talley and Lars Agreus},
  journal={European Journal of Epidemiology},
  year={2010},
  volume={25},
  pages={741-750}
}
The impact of snus (smokeless tobacco or snuff) on gastrointestinal symptoms and pathological findings is largely unknown. The authors aimed to investigate whether the exposure to different forms of tobacco influences upper gastrointestinal symptoms, histology and frequency of Helicobacter pylori infection. A random sample (n = 2,860) of the adult population of two northern Swedish municipalities Kalix and Haparanda (n = 21,610) was surveyed between December 1998 and June 2001 using a validated… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-9 OF 9 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 41 REFERENCES

Editorial. Adding harm reduction to tobacco control. Lancet

  • P. Aro
  • 2007
1 Excerpt

Minskat bruk av tobak—var står vi i dag

  • Statens Folkhälsoinstitut
  • Statistik Oktober
  • 2007
2 Excerpts

Similar Papers

Loading similar papers…